ReviewComputer methods and programs in biomedicine2025
The role of AI for improved management of breast cancer: Enhanced diagnosis and health disparity mitigation.
Review in Computer methods and programs in biomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A cross data learning architecture for breast cancer classification using mammograms.Biomedical signal processing and control · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Breast Cancer (BC) remains a leading cause of morbidity and mortality among women globally, accounting for 30% of all new cancer cases (with approximately 44,000 women dying), according to recent American Cancer Society reports. Therefore, accurate BC screening, diagnosis, and classification are crucial for timely interventions and improved patient outcomes. The main goal of this paper is to provide a comprehensive review of the latest advancements in BC detection, focusing on diagnostic BC imaging, Artificial Intelligence (AI) driven analysis, and health disparity considerations. We first examine diverse imaging techniques such as Mammography, Ultrasound, and Dynamic Contrast-Enhanced Magnetic Resonance Imaging, and provide an overview of their pros and cons. Then, we provided an intensive review of the State-of-the-Art (SOTA) literature on the role of AI in BC classification and segmentation. Lastly, we examined the role of AI in BC health disparities. A key contribution of this work lies in its integrative approach, consolidating insights from multiple research areas, imaging methods, AI-driven methodologies, and health disparities in a single resource. This paper evaluates the effectiveness of modern AI-based tools in enhancing diagnostic accuracy and discusses their potential to address biases in BC diagnosis, thus promoting equitable healthcare access. By integrating clinical, technical, and equity perspectives, this review aims to inform real-world decision-making, supporting the development of bias-aware AI tools, guiding equitable screening policy, and enhancing clinical practice in breast cancer care. Additionally, our critical analysis and discussion of recent SOTA highlights the strengths, limitations, and knowledge gaps for future directions of AI roles in BC. In total, these findings and future venue suggestions serve as a practical reference for researchers, clinicians, and policymakers, underscoring the need for interdisciplinary collaboration to harness AI's full potential in BC diagnosis and reduce global health disparities.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.